Please check my math on shares sold from 4/2/18 th
Post# of 72447
(Total Views: 801)
Posted On: 05/11/2018 6:10:43 PM
Please check my math on shares sold from 4/2/18 thru 5/9/18. I added up the total shares sold on the attached from 4kids and it came out to 6,690,500 shares sold. 4kids also mentions that the following volumes as of 5/9/18.
Volume (10 day Average) 229,990
Volume (90 day Average) 213,938
Per the 10Q IPIX sold 8M shares or an average of 285,714 shares/day through Aspire in that same period. I realize that none of us know the exact amount that Aspire sold on the open market but as mentioned by Sox, we know that Aspire has never filed a 13G indicating they own less than 5% or 7M shares of IPIX stock. The stock price dropped 30% from .51 to .36 during this period. So we know that Aspire held on to at least 1.3M shares (8M-6.69M) but represented a vast majority of the supply of shares available for sale during this period.
I am not stating that I don’t believe there are not criminal entities trying to cripple IPIX, as it is obvious that some entity with deep pockets has been funding the manipulation of the stock price going back to the orchestrated Mako/Rosen attack and has continued to date There are obvious shorting cabals but these guys are small players in the big picture and are again probably being paid off by an entity that either has competing drugs or is trying to buy IPIX assets cheaply. So to those that have argued whether it has been Aspire pressure on a thinly traded pre-revenue stock vs those that believe illegal activities including NSS, my position is that you are both right. It has been a layup for the short sellers UP TO THIS POINT. Science wins at the end and a partnership is a validation stamp and the end of dilution.
It has been painful to watch the share price spiral downward but there have been several “tells” that IPIX has communicated that tell me that:
- A B-OM deal is as good as done (negotiation stage) and will be finalized after the P results are known.
- P results have very good odds of being positive and there could be a P partnership very soon as well.
- Either of the above or possibly both will make the Aspire deal unnecessary going forward. (No more dilution)
- IPIX is exploring new facilities for corporate Headquarters. Over the next year company plans on increasing all areas of administration to include employees and facilities. If you were CEO why would you possibly do this unless you were positioning for major growth?
- IPIX has $2M in the bank ($1.3M cash plus $2M Aspire sales less $1M owed to CRO) and Leo has delayed any unnecessary expenditures.
- Evonik deal in place to produce B-OM packaging and probable B-UP foam etc. Would you sign a drug manufacturing contract if a deal wasn’t close?
- I haven’t even mentioned K which if successful could make IPIX a triple digit stock.
For a more complete list regarding the science check out posts by Drano, Sox, DaubersUP and others. The next few weeks should be exciting . GLTA longs,
Volume (10 day Average) 229,990
Volume (90 day Average) 213,938
Per the 10Q IPIX sold 8M shares or an average of 285,714 shares/day through Aspire in that same period. I realize that none of us know the exact amount that Aspire sold on the open market but as mentioned by Sox, we know that Aspire has never filed a 13G indicating they own less than 5% or 7M shares of IPIX stock. The stock price dropped 30% from .51 to .36 during this period. So we know that Aspire held on to at least 1.3M shares (8M-6.69M) but represented a vast majority of the supply of shares available for sale during this period.
I am not stating that I don’t believe there are not criminal entities trying to cripple IPIX, as it is obvious that some entity with deep pockets has been funding the manipulation of the stock price going back to the orchestrated Mako/Rosen attack and has continued to date There are obvious shorting cabals but these guys are small players in the big picture and are again probably being paid off by an entity that either has competing drugs or is trying to buy IPIX assets cheaply. So to those that have argued whether it has been Aspire pressure on a thinly traded pre-revenue stock vs those that believe illegal activities including NSS, my position is that you are both right. It has been a layup for the short sellers UP TO THIS POINT. Science wins at the end and a partnership is a validation stamp and the end of dilution.
It has been painful to watch the share price spiral downward but there have been several “tells” that IPIX has communicated that tell me that:
- A B-OM deal is as good as done (negotiation stage) and will be finalized after the P results are known.
- P results have very good odds of being positive and there could be a P partnership very soon as well.
- Either of the above or possibly both will make the Aspire deal unnecessary going forward. (No more dilution)
- IPIX is exploring new facilities for corporate Headquarters. Over the next year company plans on increasing all areas of administration to include employees and facilities. If you were CEO why would you possibly do this unless you were positioning for major growth?
- IPIX has $2M in the bank ($1.3M cash plus $2M Aspire sales less $1M owed to CRO) and Leo has delayed any unnecessary expenditures.
- Evonik deal in place to produce B-OM packaging and probable B-UP foam etc. Would you sign a drug manufacturing contract if a deal wasn’t close?
- I haven’t even mentioned K which if successful could make IPIX a triple digit stock.
For a more complete list regarding the science check out posts by Drano, Sox, DaubersUP and others. The next few weeks should be exciting . GLTA longs,
(15)
(0)